Tag Archives: GL261
In vivo imaging of immunotherapeutic glioma model
Glioblastoma remains one of the deadliest diseases faced by patients, with a median survival of less than 15 months. Therapeutic advancements in the field rely heavily on animal models, and the use of human brain tumor cells
